top of page
News & Publications
Our team is happy to share more about our mission and our products.
Domus Diagnostics Moves Closer to Delivering Affordable At-Home Molecular Test for COVID-19, Flu-A, Flu-B and RSV
$2.4M contract from the NIH's Rapid Acceleration of Diagnostics (RADx®) program accelerates development of ultra-low-cost, at-home diagnostic test. Press release viewable on BusinessWire here.
A lyophilized colorimetric RT-LAMP test kit for rapid, low-cost, at-home molecular testing of SARS-CoV-2 and other pathogens
Since our initial work described in this publication, the Domus R&D effort has led to significant simplification and improvement of the assay performance. Full-text access and supporting information is located here.
bottom of page